Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
Caledonia Mining Corporation Plc Issue of Securities to Directors and Long Term Incentive Awards
-
Caledonia Mining Corporation Plc Issue of Securities to Directors and Long Term Incentive Awards
-
Form 4 Strongbridge Biopharma For: Dec 26 Filed by: CAXTON CORP
-
Form 4 Molecular Templates, For: Dec 26 Filed by: CAXTON CORP
-
Form 4 Strongbridge Biopharma For: Dec 20 Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Janice Stipp and Stan Sokolowski Appointed to Michigan State University Foundation's Board of Directors
-
Form 4 Molecular Templates, For: Sep 25 Filed by: CAXTON CORP
-
QMA global investment teams expand with Lorne Johnson, Patrick McDonough
-
Goldman's Petershill takes minority stake in hedge fund LMR: source
-
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
-
Form D Caxton Macro (USA) LLC
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Strongbridge Biopharma (SBBP) 10% Owner Buys ~361K Shares
-
Form 4 Strongbridge Biopharma For: Aug 08 Filed by: CAXTON CORP
-
Form D/A Caxton Global Investment
-
Form 4 Strongbridge Biopharma For: Jul 30 Filed by: CAXTON CORP
-
Form 4 Strongbridge Biopharma For: Jul 24 Filed by: CAXTON CORP
-
Form 4 Strongbridge Biopharma For: Jul 19 Filed by: CAXTON CORP
-
Form 4 Strongbridge Biopharma For: Jul 16 Filed by: CAXTON CORP
-
Form SC 13G MEI Pharma, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: CAXTON CORP
-
Form 13F-HR/A CAXTON CORP For: Mar 31
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR/A CAXTON CORP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Form 4 PLY GEM HOLDINGS INC For: Apr 12 Filed by: Caxton-Iseman (Ply Gem) II, L.P.
-
Form 4 PLY GEM HOLDINGS INC For: Apr 12 Filed by: Caxton-Iseman (Ply Gem), L.P.
-
Form SC 13G SCYNEXIS INC Filed by: CAXTON CORP
-
Some U.S. macro hedge funds thrive with renewed volatility
-
Some U.S. macro hedge funds thrive with renewed volatility
-
Paulson holds stake steady in gold investments in fourth quarter of 2017: filing
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A Garrison Capital Inc. Filed by: CAXTON CORP
-
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: CAXTON CORP
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13G/A PLY GEM HOLDINGS INC Filed by: Caxton-Iseman (Ply Gem), L.P.
-
Form SC 13G/A International Seaways, Filed by: CAXTON ASSOCIATES LP
-
Stock-focused hedge funds post biggest gains among top performers
-
Form SC 13G CM Finance Inc Filed by: CAXTON CORP
-
Birner Dental Management Services, Inc. Announces Successful Capital Raise, Debt Restructuring And Changes To Board Of Directors
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
-
Form D/A HedgeForum Caxton, Ltd.
-
Form 13F-HR/A CAXTON ASSOCIATES LP For: Jun 30
-
Form SC 13G AGILE THERAPEUTICS INC Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30

